| Active Substance/INN | Metotrexato |
|---|---|
| Dosage | 2 mg/ml |
| Pharmaceutical Form | Oral solution |
| Product Type |
Jylamvo (Metotrexato)
Pharmacotherapeutic Group: Oncology
Biojam Area: Biojam Pharma Portugal
Related products
Oncology
Parkinson's disease
Vascular






